### Original Source
[https://en.wikipedia.org/wiki/Imprimis_Pharmaceuticals](https://en.wikipedia.org/wiki/Imprimis_Pharmaceuticals)

Imprimis Pharmaceuticals is a publicly traded pharmaceutical company (NASDAQ: IMMY) based in San Diego.[1][2] It makes eye drops, compounded medicines and other products.

It manufactures a pyrimethamine and leucovorin compound which may offer a low-cost "alternative" to Daraprim, a medication which gained public attention after its price in the United States was increased by over 5,000% by Martin Shkreli and Turing Pharmaceuticals.
